Showing results (191-200 of 8,341) with videos related to
Sort By:
Pageof 835
Movement Disorders : Official Journal of the Movement Disorder Society|November 17, 2017
Rethinking status dystonicusMarta Ruiz-Lopez, Alfonso FasanoMovement Disorders : Official Journal of the Movement Disorder Society|October 6, 2017
Cognitive changes in prodromal Parkinson's disease: A reviewSophie Fengler, Inga Liepelt-Scarfone, Kathrin Brockmann, et al.Movement Disorders : Official Journal of the Movement Disorder Society|July 5, 2016
Retraction: 'Alendronate and vitamin D2 for prevention of hip fracture in Parkinson's disease: A randomized controlled trial,' by Sato, Y., Iwamoto, J., Kanoko, T., and Satoh, KMovement Disorders : Official Journal of the Movement Disorder Society|September 30, 2017
Pedunculopontine nucleus deep brain stimulation in Parkinson's disease: A clinical reviewWesley Thevathasan, Bettina Debu, Tipu Aziz, et al.Movement Disorders : Official Journal of the Movement Disorder Society|April 1, 2018
Application of the Movement Disorder Society prodromal criteria in healthy G2019S-LRRK2 carriersAnat Mirelman, Rachel Saunders-Pullman, Roy N Alcalay, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1987
Continuous intracerebroventricular infusion of dopamine and dopamine agonists through a totally implanted drug delivery system in animal models of Parkinson's diseaseJ G de Yebenes, S Fahn, S Lovelle, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1987
PHNO, a novel dopamine agonist, in animal models of parkinsonismW Koller, G Herbster, J GordonMovement Disorders : Official Journal of the Movement Disorder Society|January 1, 1987
The effect of intracerebroventricular infusion of (+)-4-propyl-9-hydroxynapthoxacine (PHNO) through a totally implanted drug delivery system in rats with dopamine deficiencyJ G de Yebenes, S Fahn, V Jackson-Lewis, et al.Movement Disorders : Official Journal of the Movement Disorder Society|November 2, 2006
Report from a U.S. conference on essential tremorRodger J Elble, Movement Disorders : Official Journal of the Movement Disorder Society|November 2, 2006
Long-term benefit to pallidal deep brain stimulation in a case of dystonia secondary to pantothenate kinase-associated neurodegenerationMartin Krause, Wolfgang Fogel, Volker Tronnier, et al.Pageof 835